What is CD4+CD56+ malignancy and how should it be treated? - Wikidata - wikimedia - TriplyDB

What is CD4+CD56+ malignancy and how should it be treated?

What is CD4+CD56+ malignancy and how should it be treated?

http://www.wikidata.org/entity/Q35226503

about

Blastic Plasmacytoid Dendritic Cell Neoplasm in the Pediatric Population: A Case Series and Review of the Literature Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.Blastic Plasmacytoid Dendritic Cell Neoplasm with Pulmonary Involvement and Atypical Skin Lesion.Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemia.Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications.A rare case of blastic plasmacytoid dendritic cell neoplasm with deletion 7q.31, in the setting of heavy pre-treatment with alkylating chemotherapy.Blastic Plasmacytoid Dendritic Cell Neoplasm: Analysis of Clinicopathological Feature and Treatment Outcome of Seven Cases.Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review.Blastic plasmacytoid dendritic cell neoplasm: a single-center experience.Diffuse lung metastases in a child with blastic plasmacytoid dendritic cell neoplasm and review.Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.Infiltrative plaques on the temple. Blastic plasmacytoid dendritic cell neoplasm (BPDCN).Reduced intensity allogeneic stem cell transplant for treatment of blastic plasmacytoid dendritic cell neoplasm.Neoplasms derived from plasmacytoid dendritic cells.Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).Flow cytometry to identify bone-marrow relapse in blastic plasmacytoid dendritic cell neoplasm: a case report.Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea Efficacy of acute myeloid leukemia therapy without stem-cell transplantation in a child with blastic plasmacytoid dendritic cell neoplasm.A case of blastic plasmacytoid dendritic cell neoplasm.Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN.Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasm.Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.CLTC-ALK fusion as a primary event in congenital blastic plasmacytoid dendritic cell neoplasm.Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.Clonal evolution in the transition from cutaneous disease to acute leukaemia suggested by liquid biopsy in blastic plasmacytoid dendritic cell neoplasm.Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation--a single center experience.Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern.Azacitidine in the treatment of blastic plasmacytoid dendritic cell neoplasm: a report of 3 cases.Intracytoplasmic detection of TCL1--but not ILT7-by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis.Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms.Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

P2860

Q28083657-71DA00DF-9F57-4473-8C9F-60F2D161CFE9 Q30249813-75D68912-66F1-40B2-B5C1-6BE5A52A1A10 Q33841199-46AC6281-BD11-44FA-B351-D4B0F6CBCB74 Q34096751-24AF3AA1-9AB7-4FE6-9E3F-7B1D9425C68C Q34227741-DBD4B205-A22C-4522-9549-4AA295533C08 Q34255104-5D9C0075-005A-42DB-BC08-A39F57E61353 Q34538446-F881113F-C4AB-427C-B049-AF0AE84D80FD Q36415215-20370090-3229-49B3-871B-36CB4C9E1548 Q36579106-E5C02D41-EE62-4C32-8E6E-D57BABF97080 Q36762575-72AB4F2C-961F-4000-8A36-9CA51EC95D0B Q37975056-0F6929BB-109D-4D78-A188-6096AA039079 Q38058425-FAA0E7D1-73E0-4456-A9DA-D6146A4B5A84 Q38175299-037181BC-3C84-47C3-8DD3-1D58D7EACECC Q38213642-B398FE9B-BCCA-48A2-AD42-F4B9C7EEF66E Q38259612-A0447CF6-6A62-42D5-92BA-D90579CAB9A3 Q38388125-F5D5995D-AF2E-4732-8BA1-46B09754CE28 Q38628866-96D544A8-6537-4CB4-8B49-4E8D348D3281 Q38689894-FDA67D92-082B-44EF-80DD-792A08C51C36 Q38918870-EDC90BDE-6708-466C-867D-DCBAF06D41BC Q41491107-61C7FD6B-73E0-44E8-8AFF-AB12A77F4A85 Q41607602-E8AAA9C0-2A0F-405C-8113-53ACD97B5333 Q43156053-8FD36114-34E6-47C4-8454-211FDA15448D Q43165415-A9590C9E-C6D9-4E47-982A-028B01A4EB71 Q46058919-97209EF9-7574-4A94-818E-C143B0F19FDF Q46112355-02929F93-76D3-45CD-A49D-671678E1770C Q46118251-9D5361B1-DBD0-4509-A498-145DD80E0EFE Q46465423-B71F0866-97CD-4C8E-A9E8-5E059CF5E0DC Q47567814-A97598FA-A84C-4D57-B9F7-ACA801A5CC25 Q50118860-E4C17F17-63CC-4388-8705-52E8C482D005 Q50643131-26C58AAB-BA90-44E0-9154-D3F5E0B2841A Q52648918-41AE8FEA-A9B4-4700-8B95-7AB512446CAC Q52880354-1EBD68B3-BDEC-43DA-B41C-0231BCE8B3DF Q53269527-5DA744AC-2F83-469B-8645-4B46636E51B5 Q53641555-0106C718-E682-4A50-8CCA-59B55B77ABA2 Q55085208-2AF22B8D-2D2A-4233-A96A-46EB9CB749B1 Q58010082-52B49040-8A19-4A73-87FE-EB4493644A56

P2860

What is CD4+CD56+ malignancy and how should it be treated?

http://www.wikidata.org/entity/Q35226503

description

2003 nî lūn-bûn

@nan

2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

What is CD4+CD56+ malignancy and how should it be treated?

@ast

What is CD4+CD56+ malignancy and how should it be treated?

@en

type

label

What is CD4+CD56+ malignancy and how should it be treated?

@ast

What is CD4+CD56+ malignancy and how should it be treated?

@en

prefLabel

What is CD4+CD56+ malignancy and how should it be treated?

@ast

What is CD4+CD56+ malignancy and how should it be treated?

@en

P1433

Q35226503-7A9FB72D-3280-4BB9-A4D9-6F2C795E952F

P1476

Q35226503-AACFF8C0-63F9-404D-82F8-D3FFBA9F4DD1

P2093

Q35226503-369FDB38-D841-4887-877E-3837E2322EFF

Q35226503-4D245285-D07E-4529-B8F8-3F080C9F5E77

Q35226503-7A8B666D-FF1B-4A6F-98D5-A013896B7996

Q35226503-7D83551F-B601-45A6-84BE-C754E8121993

Q35226503-BE3BB478-F7E8-414E-AD91-93122E957D98

Q35226503-BE4EE2DF-7142-42BF-8D36-E69448131F02

Q35226503-BE8BBDF7-CE86-49D1-92E5-E26D623731FE

Q35226503-D16AA30A-6A72-4A6F-9060-46F614236C80

P2860

Q35226503-32ED25E9-FE98-45EF-9399-ADE9642DC9DE

Q35226503-695A53FF-6283-472B-9694-A6EDED2DADF2

Q35226503-80E8E0C1-59AA-4DAA-81CD-FBAD7AE2362B

Q35226503-85945E3E-258A-4BA0-B7DF-330A0DED655F

Q35226503-A244027B-EAFA-4F7C-B423-E57DE6068EA6

Q35226503-B2797048-FBD9-47BA-8624-8DA579C68667

Q35226503-B3899273-FE77-4953-8681-C76085A5F240

Q35226503-B9D9EF0E-F148-4D13-94CB-8AC5FF2FA883

Q35226503-BF39E232-F9D0-44FE-BFB9-63AD81C5AA16

Q35226503-C07DAA17-71A3-4164-9A93-431CB7DDFEBE

P2888

Q35226503-77094512-DE40-48B2-952E-312DA04E45B1

P304

Q35226503-CB40E92E-5246-4B6E-9322-CCDD4FC8A3DF

P31

Q35226503-DD70A18A-7278-4CBF-8ABF-839289FC13DB

P356

Q35226503-E937E0CF-1B6C-4B38-A927-94707A828A0C

P407

Q35226503-FC62FA0C-7D30-4C45-BC36-CB2D98B18A27

P433

Q35226503-F804F45C-3C8B-4D85-B7D0-297051771F8A

P478

Q35226503-BE1A8791-C20C-41E4-BADF-B4AB860232F9

P577

Q35226503-7DB9EE53-DD86-447B-8F01-253968BE49C1

P5875

Q35226503-0B926D04-9CA2-4B14-A187-1C19709DA41B

P698

Q35226503-3EF3908F-B5AF-447E-AE2E-392A0E03AF63

P356

P1433

Bone Marrow Transplantation

P1476

What is CD4+CD56+ malignancy and how should it be treated?

@en

P2093

Konrad Müller-Hermelink H

http://www.w3.org/2001/XMLSchema#string

Kraemer D

http://www.w3.org/2001/XMLSchema#string

Kunzmann V

http://www.w3.org/2001/XMLSchema#string

Reimer P

http://www.w3.org/2001/XMLSchema#string

Rüdiger T

http://www.w3.org/2001/XMLSchema#string

Weissinger F

http://www.w3.org/2001/XMLSchema#string

Wilhelm M

http://www.w3.org/2001/XMLSchema#string

Zettl A

http://www.w3.org/2001/XMLSchema#string

P2860

Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents.

Cutaneous monomorphous CD4- and CD56-positive large-cell lymphoma.

CD2- CD4+ CD56+ hematodermic/hematolymphoid malignancy.

Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.

A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman.

Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.

Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

Blastic NK-cell lymphoma/leukemia with T-cell receptor gamma rearrangement.

Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tract.

A case of neural cell adhesion molecule-positive peripheral T-cell lymphoma associated with human T-cell lymphotrophic virus type 1 showing an unusual involvement of the gastrointestinal tract during the course of the disease.

P2888

P304

637-646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BMT.1704215

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10412210

http://www.w3.org/2001/XMLSchema#string

P698

13130309

http://www.w3.org/2001/XMLSchema#string